Endo-BCN-PEG4-Palmitic
Endo-BCN-PEG4-Palmitic is a PEG derivative containing an endo-BCN cycloalkyne structure, a tetraethylene glycol (PEG4) linker, and a Palmitic acid fatty acid group. Endo-BCN-PEG4-Palmitic can be used for drug delivery, surface modification, and click chemistry reactions[1].
Product Specifications
UNSPSC
12352200
Hazard Statement
H302-H315-H319-H335
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Others
Smiles
[H][C@]12C([C@@H]2COC(NCCOCCOCCOCCOCCNC(CCCCCCCCCCCCCCC)=O)=O)([H])CCC#CCC1
Molecular Formula
C37H66N2O7
Molecular Weight
650.93
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Singh SS, et al. Fatty Acid Derivatization and Cyclization of the Immunomodulatory Peptide RP-182 Targeting CD206high Macrophages Improve Antitumor Activity. Mol Cancer Ther. 2024 Dec 3;23 (12) :1827-1841.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6315416-01 0.2 mL
LCA5L, CT (LCA5L, C21orf13, Lebercilin-like protein, Leber congenital amaurosis 5-like protein) (APC)
Sign In for Pricing
View Details MBS6315416-02 5x 0.2 mL
LCA5L, CT (LCA5L, C21orf13, Lebercilin-like protein, Leber congenital amaurosis 5-like protein) (APC)
Sign In for Pricing
View Details 
M3955-30C-ML550 100 µL
MRII, NT (R80) (Anti-Muellerian Hormone Type II Receptor, Anti-Muellerian Hormone Type II Receptor, AMH Type II Receptor, MIS Type II Receptor, MISRII, AMHR2, AMHR) (MaxLight 550) discontinued
Sign In for Pricing
View Details sc-426880-ACT 20 µg
Histone cluster 1 H2BC CRISPR Activation Plasmid (m)
Sign In for Pricing
View Details